Atlas Trials

Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)

Clinical trial NCT03287232 · COMPLETED

Trial details

NCT number
NCT03287232
Sponsor
EndoCeutics Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hypoactive Sexual Desire Disorder
Start date
2017-10-16
Primary completion
2019-03-08
Enrollment
653

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.